Vivos Therapeutics (VVOS) Goodwill (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Goodwill data on file, last reported at $8.6 million in Q1 2026.

• Goodwill for Q1 2026 came in at $8.6 million, up 201.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.6 million (up 201.51% YoY), and the FY2025 annual result was $8.6 million, up 206.14% from the prior year.
• Goodwill held at $8.6 million in Q1 2026 per VVOS's latest filing, from $8.6 million in the prior quarter.
• Over five years, Goodwill peaked at $8.6 million in Q4 2025 and troughed at $2.8 million in Q4 2022.
• A 5-year average of $4.2 million and a median of $2.8 million in 2022 frame the typical range for Goodwill.
• The sharpest annual moves came in 2022 and 2025: Goodwill declined 1.51% in 2022, then jumped 206.14% in 2025.
• A 5-year view of Goodwill shows it stood at $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then jumped by 206.14% to $8.6 million in 2025, then changed by 0.0% to $8.6 million in 2026.
• Business Quant data shows VVOS's Goodwill at $8.6 million in Q1 2026, $8.6 million in Q4 2025, and $8.4 million in Q3 2025.